FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 85 filers reported holding FURIEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $185,000 | 0.0% | 1,998 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $185,000 | -68.6% | 1,998 | -64.0% | 0.00% | -75.0% |
| Q2 2014 | $589,000 | +21.9% | 5,551 | 0.0% | 0.00% | +33.3% |
| Q1 2014 | $483,000 | +84.4% | 5,551 | -10.9% | 0.00% | +50.0% |
| Q4 2013 | $262,000 | -1.1% | 6,232 | +3.6% | 0.00% | 0.0% |
| Q3 2013 | $265,000 | +25.6% | 6,018 | -3.0% | 0.00% | 0.0% |
| Q2 2013 | $211,000 | – | 6,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 319,536 | $13,424,000 | 9.48% |
| Global Alpha Capital Management Ltd. | 67,120 | $2,996,000 | 4.61% |
| Consonance Capital Management LP | 648,829 | $27,257,000 | 4.47% |
| Alistair Capital Management, L.L.C. | 168,738 | $7,089,000 | 3.18% |
| Artal Group S.A. | 870,842 | $36,584,000 | 1.31% |
| Breithorn Capital Management | 48,058 | $2,019,000 | 1.13% |
| THOMPSON SIEGEL & WALMSLEY LLC | 600,615 | $25,232,000 | 0.59% |
| FRANKLIN STREET ADVISORS INC /NC | 52,325 | $2,198,000 | 0.44% |
| Visium Asset Management, LP | 312,698 | $13,136,000 | 0.26% |
| AMERICAN CAPITAL MANAGEMENT INC | 49,134 | $2,064,000 | 0.26% |